MAUDE Adverse Event Report: COVIDIEN MFG SOLUTIONS S.A. DIALYSIS UNKNOWN; CATHETER, PERITONEAL, LONG-TERM INDWELLING

Model Number DIALYSIS UNKNOWN

Device Problems Difficult to Remove (1528); Difficult to Advance (2920)

Patient Problem No Clinical Signs, Symptoms or Conditions (4582)

Event Date 07/15/2020

Event Type  malfunction  

Manufacturer Narrative

If information is provided in the future, a supplemental report will be issued.

Event Description

According to the reporter, during insertion on right subclavian, the guide wire was not threading.It was mentioned that there was no apparent damage to the guide wire or catheter (guide wire still intact).The needle was used to access the vein per the standard process and blood return was seen as expected.The guide wire did not advance into the vessel, and then was unable to be withdrawn.The catheter and guide wire were withdrawn together.They still did not get the needle loose from the guide wire after withdrawing.It was mentioned that after the first pass, the patient had a small hematoma developed which did not continue to enlarge.Pressure was held over the hematoma and the hematoma was "resolved".A second kit was obtained and the same situation occurred.Venous return was obtained on second and third pass but guidewire could not be advanced.On carotid, light pulsatile blood noted.The needle was immediately withdrawn and pressure was held for 10 minutes.At this point, procedure was terminated, and trauma surgery was called.They had to involve a consultant and additional access was created on the other side of the chest.Then moved to the left ij and us ing seldinger guidewire technique with ultrasound guidance.The vein was identified and cannulated with a localizing needle.The guide wire was placed and the skin was incised to accommodate the dilator.The skin was dilated and the catheter was inserted.The guide wire was removed and the lines were aspirated and flushed.The line was then secured in place and the procedure was completed.Chlorhexidine, standard skin preparation, was used to treat the insertion site prior to product placement.There was no damage seen on the device's box and packaging and the product/kit was still sealed upon receipt.No excessive force was used to pull/take out the product and there was nothing unusual observed on the device prior to use.There were no other products being utilized with the device and the guide wire used for the first kit was the one included in the kit.There was a small amount of blood loss and blood transfusion was not required.There was no reported patient injury.

Event Description

According to the reporter, during insertion on right subclavian of the initial healthcare provider, the guide wire was not threading.It was mentioned that there was no apparent damage to the guide wire or catheter (guide wire still intact).The needle was used to access the vein per the standard process and blood return was seen as expected.The guide wire did not advance into the vessel, and then was unable to be withdrawn.The catheter and guide wire were withdrawn together.They still did not get the needle loose from the guide wire after withdrawing.It was mentioned that after the first pass, the patient had a small hematoma developed which did not continue to enlarge.Pressure was held over the hematoma and the hematoma was "resolved".A second kit was obtained and the same situation occurred.Venous return was obtained on second and third pass but guidewire could not be advanced.On carotid, light pulsatile blood was noted.The needle was immediately withdrawn and pressure was held for 10 minutes.At this point, procedure was terminated, and trauma surgery was called.They had to involve a consultant (second healthcare provider) and additional access was creat ed on the other side of the chest.Then moved to the left ij and using seldinger guidewire technique with ultrasound guidance.The vein was identified and cannulated with a localizing needle.The guide wire was placed and the skin was incised to accommodate the dilator.The skin was dilated and the catheter was inserted.The guide wire was removed and the lines were aspirated and flushed.The line was then secured in place and the procedure was completed.Chlorhexidine, standard skin preparation, was used to treat the insertion site prior to product placement.There was no damage seen on the device's box and packaging and the product/kit was still sealed upon receipt.No excessive force was used to pull/take out the product and there was nothing unusual observed on the device prior to use.There were no other products being utilized with the device and the guide wire used for the first kit was the one included in the kit.There was a small amount of blood loss and blood transfusion was not required.There was no reported patient injury.

Manufacturer Narrative

Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.

Manufacturer Narrative

H3: evaluation summary: medtronic conducted an investigation based upon all information received.The device was available for evaluation.Visual inspection noted the guidewire was broken.It was reported that the guide wire was unable to be withdrawn and there was a guide wire issue.The reported issues were confirmed.The product analysis noted evidence that the device was not used as intended.This issue can occur if excessive force was applied to the device.The manufacturing records for each device are thoroughly reviewed prior to release to ensure that it meets all medtronic quality specifications.The instructions included with this device provide the following guidance: use the guidewire thumb advancer and straightener to insert the "j" end of the guidewire in to the introducer needle.Do not insert or withdraw the guidewire forcibly from any component; the wirer could break or unravel.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.

• Brand Name: DIALYSIS UNKNOWN
• Type of Device: CATHETER, PERITONEAL, LONG-TERM INDWELLING
• Manufacturer (Section D): COVIDIEN MFG SOLUTIONS S.A.; edificio b20, calle #2; alajuela 20101 ; CS 20101
• MDR Report Key: 11488616
• MDR Text Key: 240019023
• Report Number: 3009211636-2021-00062
• Device Sequence Number: 1
• Product Code: FJS
• Combination Product (y/n): N
• Number of Events Reported: 1
• Summary Report (Y/N): N
• Report Source: Manufacturer
• Source Type: health professional,other,use
• Type of Report: Initial,Followup,Followup
• Report Date: 04/26/2021

1 Device was Involved in the Event

1 Patient was Involved in the Event

• Date FDA Received: 03/15/2021
• Is this an Adverse Event Report?: No
• Is this a Product Problem Report?: Yes
• Device Operator: Health Professional
• Device Model Number: DIALYSIS UNKNOWN
• Device Catalogue Number: DIALYSIS UNKNOWN
• Was Device Available for Evaluation?: Device Returned to Manufacturer
• Date Returned to Manufacturer: 03/12/2021
• Date Manufacturer Received: 04/06/2021
• Is This a Reprocessed and Reused Single-Use Device?: No
• Patient Sequence Number: 1
• Patient Age: 53 YR
• Patient Weight: 93